ALT vs BR · rev $20.0K vs P/E 16, rev $6.89B
Altimmune Inc (ALT) versus Broadridge Financial Solutions Inc (BR) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
Latest reported BR revenue for 2025-06-30 was $6.89B. Net income was $839.5M. Revenue was up 5.9% from 2024-06-30 to 2025-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
ALT currently screens at market cap $527.0M. BR currently screens at market cap $17.65B and trailing P/E 16.3.
Not investment advice. Open the ALT and BR stock pages for the full models.
Not investment advice.